New patent for APGDI drug MYRBETRIQ

Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are seven patents protecting…
The post New patent for APGDI drug MYRBETRIQ appeared first on Dru…


Biotechblog